On Demand 2024 Practice Management Course

You can earn up to 5.75 AMA PRA Category 1 Credit(s)TM.

Price: $45 College members, $60 non-members

This one-day program is designed for office administrators and physician alike and delivers dynamic updates on efficiently and effectively running your allergy practice. The PMP covers key allergy practice management topics, and our presenters are all experts in their field. 

Program Outline

2024 Allergy Coding Update / College PM Resources
AI for A/I: The Great ProCon Debate/Top Tips From PM Experts To Increase Revenue and Operational Efficiency
Everything You Need To Know About 95165  / Value Based Care Options for Allergists
Harnessing Technology and Templates To Optimize Workflow / Achieving Success With Prior Authorizations

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 5.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

  • Practice administrators/managers
  • Allergist-immunologists (both new and established)
  • Fellows in training
  • Nurse managers and other clinical staff responsible for practice management activities

Learning Objectives

Upon completion of this session, participants should be able to:

  • Demonstrate an understanding of coding changes and documentation requirements that affect the specialty of allergy.
  • Explain how to access College practice management resources and how to determine which resources will be most useful to you and your practice.
  • Review ways artificial intelligence can benefit your practice, as well as associated potential risks that can impact allergists and patients.
  • Discuss revenue opportunities available to allergy practices and identify those most applicable to you and your practice.
  • Explain operational efficiency opportunities common to allergy practices and identify those most likely to benefit you and your practice.
  • Demonstrate an understanding of how to properly code and document for allergen extract mixing.
  • Employ effective strategies to manage prepayment audits, denials and appeals for 95165.
  • Explain the differences between fee-for-service payment and value-based payment models.
  • Identify value-based care payment model options for allergists.
  • Identify technology tools and EHR templates to improve practice productivity and positively influence the patient experience.
  • Employ strategies to improve prior authorization efficiency in their practice.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
  
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 Attendance
  • 5.75 CBRN
Course opens: 
11/11/2024
Course expires: 
11/10/2027
Cost:
$60.00
Rating: 
0

Melinda M. Rathkopf, MD, MBA, FACAAI
Gary N. Gross, MD, FACAAI
Jean L. Owen, MBA
Sakina Shikari Bajowala, MD
Priya J. Bansal, MD, FACAAI
Charlie F. Furr, Jr.
Todd McGee, MBA
J. Allen Meadows, MD, FACAAI
J. Wesley Sublett, MD, MPH, FACAAI
Amar Dixit, MD, MBA, FACAAI
Amy Palmer, RN
Jessica Hamady Valentin

Available Credit

  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 Attendance
  • 5.75 CBRN

Price

Cost:
$60.00
Please login or create an account to take this course.